LONDON—Ablation techniques are an ideal treatment option for some patients with kidney cancer, said Alice Gillams, MRCP, FRCR, Consultant Radiologist, The London Clinic, Harley Street. Dr. Gillams ...

SBRT showed improved LPFS over RFA in treating single recurrent small HCC, especially for tumors ≤2 cm. Both SBRT and RFA demonstrated similar PFS, OS, and safety profiles, with mild to moderate side ...

Five-year recurrence-free rates of 89.4% and 83.9% indicate durable disease control after ProSense cryoablation in localized small renal masses, supporting its role as a surgery-sparing local ...

At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors =3 cm and 83.9% ...

Interim Data confirm ProSense® cryoablation is highly effective for kidney tumors ≤3 cm and a safe procedure for kidney tumors ≤5 cm in people ineligible for surgery CAESAREA, Israel, March 24, 2025 ...

The approach is particularly suited to patients who are not fit for major surgery due to having only one functioning kidney.

New insights into the biology of kidney cancer, including those informed by scientific discoveries that earned a Nobel Prize, have led to advances in treatment and increased survival rates. New ...

Dr David Breen, consultant abdominal radiologist at University Hospital Southampton, discusses the implications of NICE's ...

Previously released interim data from 111 patients demonstrated ProSense® is safe and effective in destruction of kidney tumors with 88.7% recurrence-free rate ICESECRET, a prospective, multicenter, ...